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While avoiding hypoxemia has long been a goal of
critical care practitioners, less attention has been paid
to the potential for excessive oxygenation. Interest has
mounted recently in understanding the clinical effects
of hyperoxemia during critical illness, in particular its
impact following cardiac arrest. In this issue of Critical
Care, Dell’Anna and colleagues review available
animal and human data evaluating the impact of
hyperoxemia after cardiac arrest. They conclude
that while hyperoxemia during cardiopulmonary
resuscitation is probably desirable, it should probably
be avoided during post-resuscitation care. These
conclusions are in line with two broader themes
in contemporary critical care: that less may be more;
and that it is time to look beyond simply preventing
short-term mortality towards longer-term outcomes.Most importantly, however, they highlight the limits of
our current knowledge – for example, is there a safe upperInterest has mounted recently in understanding the clin-
ical effects of hyperoxemia during critical illness, par-
ticularly its impact following cardiac arrest. In this issue
of Critical Care, Dell’Anna and colleagues review avail-
able animal and human data evaluating the impact of
hyperoxemia after cardiac arrest [1].
When patients are acutely critically ill, initial inter-
ventions must be directed towards immediately life-
threatening issues. Significant hypoxemia can quickly
lead to cardiac arrest, so early aggressive supplemen-
tal oxygen is frequently provided either in response to
or for prevention of dangerous reductions in the ar-
terial partial pressure of oxygen. Once a patient is
stabilized and the focus appropriately turns to urgent
diagnosis and treatment, however, often little effort is
made to minimize the amount of supplemental oxygen
delivered. In fact, the majority of mechanically ventilatedCorrespondence: hgershen@montefiore.org
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unless otherwise stated.patients continue to receive excess supplemental oxygen
throughout their ICU stay [2,3]. Adverse effects of excess
oxygen are best understood in the brain and the systemic
circulation. Hyperoxemia can induce cerebral vasocon-
striction [4], neuronal cell death [5], and seizures [6,7]. In
addition, hyperoxemia reduces the cardiac index and heart
rate while increasing peripheral vascular resistance [8,9].
Given the major neurologic and hemodynamic challenges
faced by many critically ill patients, hyperoxemia may be
especially concerning in this population.
In their article, Dell’Anna and colleagues provide an ex-
cellent perspective on hyperoxemia following cardiac arrest
[1]. After exploring the pathophysiology of hyperoxemia in
the setting of ischemia–reperfusion brain injury, they detail
animal and human studies of hyperoxemia following car-
diac arrest. They conclude that while hyperoxemia is
probably prudent during resuscitation, avoiding hyperoxe-
mia is probably desirable in the post-resuscitation phase.
limit for arterial partial pressure of oxygen? Is even a sin-
gle episode of hyperoxemia detrimental? What is the role
of carbon dioxide? – and wisely call for further study. Of
note, a recent meta-analysis based on many of the same
studies reviewed by Dell’Anna and colleagues found that
while hyperoxemia following cardiac arrest was associated
with an increased risk of in-hospital mortality (odds ratio:
1.40, 95% confidence interval: 1.02 to 1.93), the heterogen-
eity among studies precluded firm conclusions about the
practice [10].
In focusing on the potential downsides of post-arrest
hyperoxemia, Dell’Anna and colleagues hit on two import-
ant themes of current critical care research and practice.
First, they implore us to consider the idea that doing more
is not necessarily in our patients’ best interest – a concept
that has taken hold recently in the critical care commu-
nity. In the United States, the Critical Care Societies
Collaborative’s contribution to the Choosing Wisely
Campaign suggests consideration of the merits of doing
less [11]. For example, influential studies have suggested
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ventilation [13]. While blood transfusion and sedation are
clearly needed for some cases of anemia and agitation, re-
spectively, too much of either can cause harm. Critical
care has evolved to include doing less, in many cases, as a
thoughtful alternative to doing more – not only when
goals of care are palliation, but also when the goal is to in-
crease chances of survival or to improve other clinical
outcomes.
A second theme addressed by this perspective is the
focus on long-term goals versus short-term goals. In
evaluating the impact of hyperoxemia after initial resus-
citation, Dell’Anna and colleagues shift focus beyond re-
turn of spontaneous circulation to include the impact on
post-arrest outcomes. More broadly, this shift in focus
can be seen in the critical care community as interest
moves from solely evaluating short-term (in-hospital or
30-day) survival to longer-term survival (months rather
than weeks or days) and alternative patient-centered out-
comes such as quality of life and functional recovery
[14,15]. Having improved our ability to achieve the trad-
itional primary mission in critical care – keeping people
alive– we now turn our knowledge, insights and atten-
tion to optimizing what it means to be a survivor.
Hyperoxemia in the post-resuscitation phase following
cardiac arrest is probably detrimental, yet the nuances of
this association are as yet unknown. As Dell’Anna and
colleagues state, further study is certainly needed to
fine-tune our understanding. With such insight we will
hopefully learn at what point ‘enough’ oxygen becomes
‘too much’ and what impact ‘too much’ has on short-
term survival, long-term survival, and quality of life.
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